Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... (OMJ), compare these findings with those for osteonecrosis of the jaw (ONJ) secondary to bisphosphonate therapy and discuss recent findings that the pathogenesis of ONJ may represent a ...
2009 NOV 9 ... (phase 2). Osteoporosis treatment was defined as initiating anti-fracture therapy (bisphosphonate, raloxifene, nasal calcitonin and teriparatide) after fracture in those previously ...
2009 NOV 16 ... with partners such as Novo Nordisk for oral insulin and GLP-1. Amerol (MER 103), an oral bisphosphonate for the treatment of osteoporosis, has completed Phase II(b) clinical trials. Acyline ...
2009 NOV 16 ... on its GIPET technology. • Orazol (MER 101) is an oral bisphosphonate for oncology indications currently in Phase II development. This product aims to allow ...
2009 NOV 16 ... treatment and greater comfort. Orazol (MER 101) is an oral bisphosphonate for oncology indications currently in Phase II development. This product aims to allow ...
2009 NOV 9 ... Osteoporosis, Treatment, Therapy, Risedronate, Antihypocalcemic, Antiresorptive, Bisphosphonate, Radiology, Bone. This article was prepared by Biotech Business Week ...
2009 NOV 23 ... Chicago. The researchers concluded: "This finding indicates that bisphosphonate therapy remains effective when initiated later in the course of androgen deprivation ...
2009 NOV 2 ... (Prevention of vertebral fractures in osteoporosis: mixed treatment comparison of bisphosphonate therapies. Current Medical Research and Opinion, 2009;25(8):1861-1868). For ...
2009 NOV 16 ... "Occurrence of atrial fibrillation (AF) amongst bisphosphonate users has been increasingly reported but results are conflicting. We performed a ...
2009 NOV 23 ... monotherapy.' According to a study from Japan, "Herein, we report a rare case in which bisphosphonate zoledronic acid (ZA) effectively treated not only multiple bone metastases but also ...
2009 NOV 2 ... did not respond to the treatment of his celiac disease but was completely reversed by bisphosphonate therapy. Autoantibodies against osteoprotegerin were detected in three additional ...
2009 NOV 2 ... from London, the United Kingdom, "Osteonecrosis of the jaw bones is a complication of bisphosphonate (BP) drug usage characterised by trans-mucosal exposure of necrotic bone, often followed ...
2009 NOV 24 ... published their study in the Journal of Materials Science - Materials in Medicine (Bisphosphonate incorporation in surgical implant coatings by fast loading and co-precipitation at low ...
2009 NOV 2 ... and Opinion (Weekly versus monthly drug regimens: 1-year compliance and persistence with bisphosphonate therapy. Current Medical Research and Opinion, 2009;25(8):1831-1839). For ...
2009 NOV 2 ... data of several treatment options, studies have shown that the cost-effectiveness of bisphosphonate therapy is mainly dependent on drug efficacy rather than persistence or dosing ...
